russjcardiolРоссийский кардиологический журналRussian Journal of Cardiology1560-40712618-7620«SILICEA-POLIGRAF» LLC10.15829/1560-4071-2022-4993russjcardiol-4993Research ArticleОБЗОРЫ ЛИТЕРАТУРЫREVIEWКардиомиопатия такоцубо. Обзор данных литературы: понятие, эпидемиология, патогенез. Часть ITakotsubo cardiomyopathy. Literature review: concept, epidemiology, pathogenesis. Part Ihttps://orcid.org/0000-0002-1898-084XБолдуеваС. А.BolduevaS. A.

Светлана Афанасьевна Болдуева — доктор медицинских наук, профессор, зав. кафедрой факультетской терапии.

Санкт-Петербург

St. Petersburg

svetlanaboldueva@mail.ruhttps://orcid.org/0000-0002-3107-1691ЕвдокимовД. С.EvdokimovD. S.

Дмитрий Сергеевич Евдокимов — аспирант кафедры факультетской терапии.

Санкт-Петербург

St. Petersburg

kasabian244@gmail.comФГБОУ ВО Северо-Западный государственный медицинский университет им. И.И. МечниковаРоссияI.I. Mechnikov North-Western State Medical UniversityRussian Federation202213092022273SОбразование49934993Copyright © Болдуева С.А., Евдокимов Д.С., 20222022Болдуева С.А., Евдокимов Д.С.Boldueva S.A., Evdokimov D.S.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://russjcardiol.elpub.ru/jour/article/view/4993

В обзоре представлены современные данные по проблеме кардиомиопатии такоцубо, затронуты основные вопросы эпидемиологии, клинической картины, критериев диагностики, а также общие патофизиологические механизмы развития заболевания.

Up-to-date data on the problem of takotsubo cardiomyopathy, including key issues of epidemiology, clinical presentation, diagnostic criteria, and general pathophysiological mechanisms of the disease is presented in review.

кардиомиопатия такоцубоэпидемиологияпатогенезпатоморфология.takotsubo syndromeepidemiologypathogenesispathomorphologyReferencesGhadri JR, Wittstein IS, Prasad A, et al. International Expert Consensus Document on Takotsubo Syndrome (Part I): Clinical Characteristics, Diagnostic Criteria, and Pathophysiology. Eur. Heart J. 2018;39:2032-46. doi:10.1093/eurheartj/ehy076.Ghadri JR, Wittstein IS, Prasad A, et al. International Expert Consensus Document on Takotsubo Syndrome (Part I): Clinical Characteristics, Diagnostic Criteria, and Pathophysiology. Eur. Heart J. 2018;39:2032-46. doi:10.1093/eurheartj/ehy076.Меерсон Ф.З. Патогенез и предупреждение стрессорных и ишемических повреждений сердца. М.: Медицина, 1984. p.269.Meyerson FZ. Pathogenesis and prevention of stress and ischemic heart damage. M.:Medicine, 1984. p. 269. (In Russ.)Amin HZ, Amin LZ, Pradipta A. Takotsubo Cardiomyopathy: A Brief Review. J Med Life. 2020;13(1):3-7. doi:10.25122/jml-2018-0067.Amin HZ, Amin LZ, Pradipta A. Takotsubo Cardiomyopathy: A Brief Review. J Med Life. 2020;13(1):3-7. doi:10.25122/jml-2018-0067.Templin C, Ghadri JR, Diekmann J, et al. Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy. N. Engl. J. Med. 2015;373:929-38. doi:10.1056/NEJMoa1406761.Templin C, Ghadri JR, Diekmann J, et al. Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy. N. Engl. J. Med. 2015;373:929-38. doi:10.1056/NEJMoa1406761.Jabri A, Kalra A, Kumar A, et al. Incidence of Stress Cardiomyopathy During the Coronavirus Disease 2019 Pandemic. JAMA Netw Open. 2020;3(7):e2014780. doi:10.1001/jamanetworkopen.2020.14780.Jabri A, Kalra A, Kumar A, et al. Incidence of Stress Cardiomyopathy During the Coronavirus Disease 2019 Pandemic. JAMA Netw Open. 2020;3(7):e2014780. doi:10.1001/jamanetworkopen.2020.14780.Napp LC, Bauersachs J. Takotsubo syndrome: between evidence, myths, and misunderstandings. Herz. 2020;45(3):252-66. doi:10.1007/s00059-020-04906-2.Napp LC, Bauersachs J. Takotsubo syndrome: between evidence, myths, and misunderstandings. Herz. 2020;45(3):252-66. doi:10.1007/s00059-020-04906-2.Rawish E, Stiermaier T, Santoro F, et al. Current Knowledge and Future Challenges in Takotsubo Syndrome: Part 1-Pathophysiology and Diagnosis. J Clin Med. 2021;10(3):479. doi:10.3390/jcm10030479.Rawish E, Stiermaier T, Santoro F, et al. Current Knowledge and Future Challenges in Takotsubo Syndrome: Part 1-Pathophysiology and Diagnosis. J Clin Med. 2021;10(3):479. doi:10.3390/jcm10030479.Citro R, Radano I, Parodi G, et al. Long-term outcome in patients with Takotsubo syndrome presenting with severely reduced left ventricular ejection fraction. Eur J Heart Fail. 2019;21(6):781-9. doi:10.1002/ejhf.1373.Citro R, Radano I, Parodi G, et al. Long-term outcome in patients with Takotsubo syndrome presenting with severely reduced left ventricular ejection fraction. Eur J Heart Fail. 2019;21(6):781-9. doi:10.1002/ejhf.1373.Болдуева С. А., Третьякова Н. С., Швец Н. С., Феоктистова В. С. Развитие синдрома такоцубо в период госпитализации по поводу тромбоэмболии легочной артерии: клиническое наблюдение. Кардиология. 2018;58(3S):64-8. doi:10.18087/cardio.2452.Boldueva SA, Tretyakova NS, Shvetc NS, Feoktistova VS. Secondary form of Takotsubo syndrome, developed on pulmonary embolism. Kardiologiia. 2018;(3S):64-8. (In Russ.) doi:10.18087/cardio.2452.Мазнев Д.С., Болдуева С.А., Задворьев С.Ф. и др. Синдром такоцубо в сочетании с инфарктом миокарда 2-го типа у пациентки пожилого возраста с коронавирусной инфекцией. Профилактическая медицина. 2021;24(11):80-6. doi:10.17116/profmed20212411180.Maznev DS, Boldueva SA, Zadvoriev SF, et al. Takotsubo syndrome combined with myocardial infarction type 2 in an elderly patient with coronavirus infection. Profilakticheskaya Meditsina. 2021;24(11):80-6. (In Russ.) doi:10.17116/profmed20212411180.Suzuki H, Matsumoto Y, Kaneta T, et al. Evidence for brain activation in patients with takotsubo cardiomyopathy. Circ J. 2014;78(1):256-8. doi:10.1253/circj.cj-13-1276.Suzuki H, Matsumoto Y, Kaneta T, et al. Evidence for brain activation in patients with takotsubo cardiomyopathy. Circ J. 2014;78(1):256-8. doi:10.1253/circj.cj-13-1276.Wang X, Pei J, Hu X. The Brain-Heart Connection in Takotsubo Syndrome: The Central Nervous System, Sympathetic Nervous System, and Catecholamine Overload. Cardiol Res Pract. 2020:4150291. doi:10.1155/2020/4150291.Wang X, Pei J, Hu X. The Brain-Heart Connection in Takotsubo Syndrome: The Central Nervous System, Sympathetic Nervous System, and Catecholamine Overload. Cardiol Res Pract. 2020:4150291. doi:10.1155/2020/4150291.Hiestand T, Hänggi J, Klein C, et al. Takotsubo Syndrome Associated With Structural Brain Alterations of the Limbic System. J Am Coll Cardiol. 2018;71(7):809-11. doi:10.1016/j.jacc.2017.12.022.Hiestand T, Hänggi J, Klein C, et al. Takotsubo Syndrome Associated With Structural Brain Alterations of the Limbic System. J Am Coll Cardiol. 2018;71(7):809-11. doi:10.1016/j.jacc.2017.12.022.Klein C, Hiestand T, Ghadri JR, et al. Takotsubo Syndrome - Predictable from brain imaging data. Sci Rep. 2017;7(1):5434. doi:10.1038/s41598-017-05592-7.Klein C, Hiestand T, Ghadri JR, et al. Takotsubo Syndrome - Predictable from brain imaging data. Sci Rep. 2017;7(1):5434. doi:10.1038/s41598-017-05592-7.Templin C, Hänggi J, Klein C, et al. Altered limbic and autonomic processing supports brain-heart axis in Takotsubo syndrome. Eur Heart J. 2019;40(15):1183-7. doi:10.1093/eurheartj/ehz068.Templin C, Hänggi J, Klein C, et al. Altered limbic and autonomic processing supports brain-heart axis in Takotsubo syndrome. Eur Heart J. 2019;40(15):1183-7. doi:10.1093/eurheartj/ehz068.Summers MR, Lennon RJ, Prasad A. Pre-morbid psychiatric and cardiovascular diseases in apical ballooning syndrome (tako-tsubo/stress-induced cardiomyopathy): potential predisposing factors? J Am Coll Cardiol. 2010;55(7):700-1. doi:10.1016/j.jacc.2009.10.031.Summers MR, Lennon RJ, Prasad A. Pre-morbid psychiatric and cardiovascular diseases in apical ballooning syndrome (tako-tsubo/stress-induced cardiomyopathy): potential predisposing factors? J Am Coll Cardiol. 2010;55(7):700-1. doi:10.1016/j.jacc.2009.10.031.Barton DA, Dawood T, Lambert EA, et al. Sympathetic activity in major depressive disorder: identifying those at increased cardiac risk? J Hypertens. 2007;25:2117-24. doi:10.1097/HJH.0b013e32829baae7.Barton DA, Dawood T, Lambert EA, et al. Sympathetic activity in major depressive disorder: identifying those at increased cardiac risk? J Hypertens. 2007;25:2117-24. doi:10.1097/HJH.0b013e32829baae7.Sciagrà R, Parodi G, Del Pace S, et al. Abnormal response to mental stress in patients with Takotsubo cardiomyopathy detected by gated single photon emission computed tomography. Eur J Nucl Med Mol Imaging. 2010;37(4):765-72. doi:10.1007/s00259-009-1362-z.Sciagrà R, Parodi G, Del Pace S, et al. Abnormal response to mental stress in patients with Takotsubo cardiomyopathy detected by gated single photon emission computed tomography. Eur J Nucl Med Mol Imaging. 2010;37(4):765-72. doi:10.1007/s00259-009-1362-z.Akashi YJ, Nakazawa K, Sakakibara M, et al. The clinical features of takotsubo cardiomyopathy. QJM. 2003;96(8):563-73. doi:10.1093/qjmed/hcg096.Akashi YJ, Nakazawa K, Sakakibara M, et al. The clinical features of takotsubo cardiomyopathy. QJM. 2003;96(8):563-73. doi:10.1093/qjmed/hcg096.Okura H. Update of takotsubo syndrome in the era of COVID-19. J Cardiol. 2021;77(4):361- 9. doi:10.1016/j.jjcc.2020.10.004.Okura H. Update of takotsubo syndrome in the era of COVID-19. J Cardiol. 2021;77(4):361- 9. doi:10.1016/j.jjcc.2020.10.004.Paur H, Wright PT, Sikkel MB, et al. High Levels of Circulating Epinephrine Trigger Apical Cardiodepression in a β2-Adrenergic Receptor/Gi–Dependent Manner. Circulation. 2012;126:697-706. doi:10.1161/circulationaha.112.111591.Paur H, Wright PT, Sikkel MB, et al. High Levels of Circulating Epinephrine Trigger Apical Cardiodepression in a β2-Adrenergic Receptor/Gi–Dependent Manner. Circulation. 2012;126:697-706. doi:10.1161/circulationaha.112.111591.Gurevich VV, Gurevich EV. GPCR Signaling Regulation: The Role of GRKs and Arrestins. Front Pharmacol. 2019;10:125. doi:10.3389/fphar.2019.00125.Gurevich VV, Gurevich EV. GPCR Signaling Regulation: The Role of GRKs and Arrestins. Front Pharmacol. 2019;10:125. doi:10.3389/fphar.2019.00125.Nakano T, Onoue K, Nakada Y, et al. Alteration of β-Adrenoceptor Signaling in Left Ventricle of Acute Phase Takotsubo Syndrome: a Human Study. Sci Rep. 2018;8(1):12731. doi:10.1038/s41598-018-31034-z.Nakano T, Onoue K, Nakada Y, et al. Alteration of β-Adrenoceptor Signaling in Left Ventricle of Acute Phase Takotsubo Syndrome: a Human Study. Sci Rep. 2018;8(1):12731. doi:10.1038/s41598-018-31034-z.Болезни сердца по Браунвальду: руководство по сердечно-сосудистой медицине, Под ред. П. Либби и др.; пер. с англ., под общ. ред. Р. Г. Оганова. В 4т. Том3: главы 38-60. М.: Логосфера, 2013. 728с.: Перевод изд. ISBN: 978-5-98657-029-7.Braunwald’s heart disease: a textbook of cardiovascular medicine, Peter Libby, et al., 8th ed. (In Russ.) ISBN: 978-5-98657-029-7.Bolli R, Marbán E. Molecular and cellular mechanisms of myocardial stunning. Physiol Rev. 1999;79(2):609-34. doi:10.1152/physrev.1999.79.2.609.Bolli R, Marbán E. Molecular and cellular mechanisms of myocardial stunning. Physiol Rev. 1999;79(2):609-34. doi:10.1152/physrev.1999.79.2.609.Kumar A, Pappachan JM, Fernandez CJ. Catecholamine-induced cardiomyopathy: an endocrinologist’s perspective. Rev Cardiovasc Med. 2021;22(4):1215-28. doi:10.31083/j.rcm2204130.Kumar A, Pappachan JM, Fernandez CJ. Catecholamine-induced cardiomyopathy: an endocrinologist’s perspective. Rev Cardiovasc Med. 2021;22(4):1215-28. doi:10.31083/j.rcm2204130.Manousek J, Kala P, Lokaj P, et al. Oxidative Stress in Takotsubo Syndrome-Is It Essential for an Acute Attack? Indirect Evidences Support Multisite Impact Including the Calcium Overload-Energy Failure Hypothesis. Front Cardiovasc Med. 2021;8:732708. doi:10.3389/fcvm.2021.732708.Manousek J, Kala P, Lokaj P, et al. Oxidative Stress in Takotsubo Syndrome-Is It Essential for an Acute Attack? Indirect Evidences Support Multisite Impact Including the Calcium Overload-Energy Failure Hypothesis. Front Cardiovasc Med. 2021;8:732708. doi:10.3389/fcvm.2021.732708.Malyshev IY, Manukhina EB. Stress, adaptation, and nitric oxide. Biochemistry (Mosc). 1998;63(7):840-53.Malyshev IY, Manukhina EB. Stress, adaptation, and nitric oxide. Biochemistry (Mosc). 1998;63(7):840-53.El-Battrawy I, Zhao Z, Lan H, et al. Estradiol protection against toxic effects of catecholamine on electrical properties in human-induced pluripotent stem cell derived cardiomyocytes. Int J Cardiol. 2018;254:195-202. doi:10.1016/j.ijcard.2017.11.007.El-Battrawy I, Zhao Z, Lan H, et al. Estradiol protection against toxic effects of catecholamine on electrical properties in human-induced pluripotent stem cell derived cardiomyocytes. Int J Cardiol. 2018;254:195-202. doi:10.1016/j.ijcard.2017.11.007.Brenner R, Weilenmann D, Maeder MT, et al. Clinical characteristics, sex hormones, and long-term follow-up in Swiss postmenopausal women presenting with Takotsubo cardiomyopathy. Clin Cardiol. 2012;35(6):340-7. doi:10.1002/clc.21986.Brenner R, Weilenmann D, Maeder MT, et al. Clinical characteristics, sex hormones, and long-term follow-up in Swiss postmenopausal women presenting with Takotsubo cardiomyopathy. Clin Cardiol. 2012;35(6):340-7. doi:10.1002/clc.21986.Surikow SY, Nguyen TH, Stafford I, et al. Nitrosative Stress as a Modulator of Inflammatory Change in a Model of Takotsubo Syndrome. JACC Basic Transl Sci. 2018;3(2):213-26. doi:10.1016/j.jacbts.2017.10.002.Surikow SY, Nguyen TH, Stafford I, et al. Nitrosative Stress as a Modulator of Inflammatory Change in a Model of Takotsubo Syndrome. JACC Basic Transl Sci. 2018;3(2):213-26. doi:10.1016/j.jacbts.2017.10.002.Hartmann C, Radermacher P, Wepler M, Nußbaum B. Non-Hemodynamic Effects of Catecholamines. Shock. 2017;48(4):390-400. doi:10.1097/SHK.0000000000000879.Hartmann C, Radermacher P, Wepler M, Nußbaum B. Non-Hemodynamic Effects of Catecholamines. Shock. 2017;48(4):390-400. doi:10.1097/SHK.0000000000000879.Patel SM, Lerman A, Lennon RJ, Prasad A. Impaired coronary microvascular reactivity in women with apical ballooning syndrome (Takotsubo/stress cardiomyopathy). Eur Heart J Acute Cardiovasc Care. 2013;2(2):147-52. doi:10.1177/2048872613475891.Patel SM, Lerman A, Lennon RJ, Prasad A. Impaired coronary microvascular reactivity in women with apical ballooning syndrome (Takotsubo/stress cardiomyopathy). Eur Heart J Acute Cardiovasc Care. 2013;2(2):147-52. doi:10.1177/2048872613475891.Del Buono MG, Montone RA, Camilli M, et al. Coronary Microvascular Dysfunction Across the Spectrum of Cardiovascular Diseases: JACC State-of-the-Art Review. J Am Coll Cardiol. 2021;78(13):1352-71. doi:10.1016/j.jacc.2021.07.042.Del Buono MG, Montone RA, Camilli M, et al. Coronary Microvascular Dysfunction Across the Spectrum of Cardiovascular Diseases: JACC State-of-the-Art Review. J Am Coll Cardiol. 2021;78(13):1352-71. doi:10.1016/j.jacc.2021.07.042.Литвицкий П.Ф., Сандриков В.А., Демуров Е.А. Адаптивные и патогенные эффекты реперфузии и реоксигенации миокарда. М.: Медицина, 1994. р. 318. ISBN: 5-225-02888-8.Litvitsky PF, Sandrikov VA, Demurov EA. Adaptive and pathogenic effects of reperfusion and reoxygenation of the myocardium. M.: Medicine, 1994. р. 318. (In Russ.) ISBN: 5-225-02888-8.Vitale C, Rosano GM, Kaski JC. Role of Coronary Microvascular Dysfunction in Takotsubo Cardiomyopathy. Circ J. 2016;80(2):299-305. doi:10.1253/circj.CJ-15-1364.Vitale C, Rosano GM, Kaski JC. Role of Coronary Microvascular Dysfunction in Takotsubo Cardiomyopathy. Circ J. 2016;80(2):299-305. doi:10.1253/circj.CJ-15-1364.Болдуева С.А., Рыжикова М.В., Швец Н. С. и др. Синдром такоцубо как острая форма микроваскулярной стенокардии. Описание клинического случая. Рациональная фармакотерапия в кардиологии 2017;13(4):489-94. doi:10.20996/1819-6446-2017-13-4-489-494.Boldueva SA, Ryzhikova MV, Shvets NS, et al. Takotsubo Syndrome as Acute Form of Microvascular Angina. Clinical Case. Rational Pharmacotherapy in Cardiology. 2017;13(4):489-94. (In Russ.) doi:10.20996/1819-6446-2017-13-4-489-494.Yalta K, Yetkin E, Yalta T. Systemic inflammation in patients with Takotsubo syndrome: a review of mechanistic and clinical implications. Monaldi Arch Chest Dis. 2021;91(2):10.4081/monaldi.2021.1718. doi:10.4081/monaldi.2021.1718.Yalta K, Yetkin E, Yalta T. Systemic inflammation in patients with Takotsubo syndrome: a review of mechanistic and clinical implications. Monaldi Arch Chest Dis. 2021;91(2):10.4081/monaldi.2021.1718. doi:10.4081/monaldi.2021.1718.Lachmet-Thébaud L, Marchandot B, Matsushita K, et al. Systemic Inflammatory Response Syndrome Is a Major Determinant of Cardiovascular Outcome in Takotsubo Syndrome. Circ J. 2020;84(4):592-600. doi:10.1253/circj.CJ-19-1088.Lachmet-Thébaud L, Marchandot B, Matsushita K, et al. Systemic Inflammatory Response Syndrome Is a Major Determinant of Cardiovascular Outcome in Takotsubo Syndrome. Circ J. 2020;84(4):592-600. doi:10.1253/circj.CJ-19-1088.Scally C, Abbas H, Ahearn T, et al. Myocardial and Systemic Inflammation in Acute StressInduced (Takotsubo) Cardiomyopathy. Circulation. 2019;139:1581-92. doi:10.1161/CIRCULATIONAHA.118.037975.Scally C, Abbas H, Ahearn T, et al. Myocardial and Systemic Inflammation in Acute StressInduced (Takotsubo) Cardiomyopathy. Circulation. 2019;139:1581-92. doi:10.1161/CIRCULATIONAHA.118.037975.Wilson HM, Cheyne L, Brown PAJ, et al. Characterization of the Myocardial Inflammatory Response in Acute Stress-Induced (Takotsubo) Cardiomyopathy. JACC Basic Transl. Sci. 2018;3:766-78. doi:10.1016/j.jacbts.2018.08.006.Wilson HM, Cheyne L, Brown PAJ, et al. Characterization of the Myocardial Inflammatory Response in Acute Stress-Induced (Takotsubo) Cardiomyopathy. JACC Basic Transl. Sci. 2018;3:766-78. doi:10.1016/j.jacbts.2018.08.006.Chen Q, Zhang W, Sadana N, Chen X. Estrogen receptors in pain modulation: cellular signaling. Biol Sex Differ. 2021;12(1):22. doi:10.1186/s13293-021-00364-5.Chen Q, Zhang W, Sadana N, Chen X. Estrogen receptors in pain modulation: cellular signaling. Biol Sex Differ. 2021;12(1):22. doi:10.1186/s13293-021-00364-5.Omerovic E, Citro R, Bossone E, et al. Pathophysiology of Takotsubo syndrome — a joint scientific statement from the Heart Failure Association Takotsubo Syndrome Study Group and Myocardial Function Working Group of the European Society of Cardiology — Part 2: vascular pathophysiology, gender and sex hormones, genetics, chronic cardiovascular problems and clinical implications. Eur J Heart Fail. 2022;24(2):274-286. doi:10.1002/ejhf.2368.Omerovic E, Citro R, Bossone E, et al. Pathophysiology of Takotsubo syndrome — a joint scientific statement from the Heart Failure Association Takotsubo Syndrome Study Group and Myocardial Function Working Group of the European Society of Cardiology — Part 2: vascular pathophysiology, gender and sex hormones, genetics, chronic cardiovascular problems and clinical implications. Eur J Heart Fail. 2022;24(2):274-286. doi:10.1002/ejhf.2368.Machuki JO, Zhang HY, Harding SE, Sun H. Molecular pathways of oestrogen receptors and β-adrenergic receptors in cardiac cells: Recognition of their similarities, interactions and therapeutic value. Acta Physiol (Oxf). 2018;222(2):e12978. doi:10.1111/apha.12978.Machuki JO, Zhang HY, Harding SE, Sun H. Molecular pathways of oestrogen receptors and β-adrenergic receptors in cardiac cells: Recognition of their similarities, interactions and therapeutic value. Acta Physiol (Oxf). 2018;222(2):e12978. doi:10.1111/apha.12978.Boyd B, Solh T. Takotsubo cardiomyopathy: Review of broken heart syndrome. JAAPA. 2020;33(3):24-9. doi:10.1097/01.JAA.0000654368.35241.fc.Boyd B, Solh T. Takotsubo cardiomyopathy: Review of broken heart syndrome. JAAPA. 2020;33(3):24-9. doi:10.1097/01.JAA.0000654368.35241.fc.Möller C, Stiermaier T, Brabant G, et al. Comprehensive assessment of sex hormones in Takotsubo syndrome. Int J Cardiol. 2018;250:11-5. doi:10.1016/j.ijcard.2017.10.047.Möller C, Stiermaier T, Brabant G, et al. Comprehensive assessment of sex hormones in Takotsubo syndrome. Int J Cardiol. 2018;250:11-5. doi:10.1016/j.ijcard.2017.10.047.Rueda D, Aguirre R, Contardo D, et al. Takotsubo Myocardiopathy and Hyperthyroidism: A Case Report and Literature Review. Am J Case Rep. 2017;18:865-70. doi:10.12659/ajcr.905121.Rueda D, Aguirre R, Contardo D, et al. Takotsubo Myocardiopathy and Hyperthyroidism: A Case Report and Literature Review. Am J Case Rep. 2017;18:865-70. doi:10.12659/ajcr.905121.Balsa AM, Ferreira AR, Alves M, Guimarães J. Takotsubo Cardiomyopathy Associated with Levothyroxine Over-replacement. Eur Endocrinol. 2017;13(1):30-2. doi:10.17925/EE.2017.13.01.30.Balsa AM, Ferreira AR, Alves M, Guimarães J. Takotsubo Cardiomyopathy Associated with Levothyroxine Over-replacement. Eur Endocrinol. 2017;13(1):30-2. doi:10.17925/EE.2017.13.01.30.Aweimer A, El-Battrawy I, Akin I, et al. Abnormal thyroid function is common in takotsubo syndrome and depends on two distinct mechanisms: results of a multicentre observational study. J Intern Med. 2021;289(5):675-87. doi:10.1111/joim.13189.Aweimer A, El-Battrawy I, Akin I, et al. Abnormal thyroid function is common in takotsubo syndrome and depends on two distinct mechanisms: results of a multicentre observational study. J Intern Med. 2021;289(5):675-87. doi:10.1111/joim.13189.Madias JE. Low prevalence of diabetes mellitus in patients with takotsubo syndrome: a plausible "protective" effect with pathophysiologic connotations. European Heart Journal: Acute Cardiovascular Care. 2016;5(2):164-70. doi:10.1177/2048872615570761.Madias JE. Low prevalence of diabetes mellitus in patients with takotsubo syndrome: a plausible "protective" effect with pathophysiologic connotations. European Heart Journal: Acute Cardiovascular Care. 2016;5(2):164-70. doi:10.1177/2048872615570761.Kato K, Sakai Y, Ishibashi I, et al. Predictors of in-hospital cardiac complications in patients with Takotsubo syndrome. Heart Vessels. 2018;33(10):1214-9. doi:10.1007/s00380-018-1172-y.Kato K, Sakai Y, Ishibashi I, et al. Predictors of in-hospital cardiac complications in patients with Takotsubo syndrome. Heart Vessels. 2018;33(10):1214-9. doi:10.1007/s00380-018-1172-y.Núñez-Gil IJ, Vedia O, Almendro-Delia M, et al. Takotsubo syndrome and cancer, clinical and prognostic implications, insights of RETAKO. Implicaciones clínicas y pronósticas en síndrome de Takotsubo y cáncer: percepciones del registro RETAKO. Med Clin (Barc). 2020;155(12):521-8. doi:10.1016/j.medcli.2020.01.033.Núñez-Gil IJ, Vedia O, Almendro-Delia M, et al. Takotsubo syndrome and cancer, clinical and prognostic implications, insights of RETAKO. Implicaciones clínicas y pronósticas en síndrome de Takotsubo y cáncer: percepciones del registro RETAKO. Med Clin (Barc). 2020;155(12):521-8. doi:10.1016/j.medcli.2020.01.033.Yerasi C, Tripathi B, Banga S, et al. Predictors of 90-Day Readmission and in-Hospital Mortality in Takotsubo Cardiomyopathy: An Analysis of 28,079 Index Admissions. Cardiovasc Revasc Med. 2019;20(11):973-9. doi:10.1016/j.carrev.2019.08.004.Yerasi C, Tripathi B, Banga S, et al. Predictors of 90-Day Readmission and in-Hospital Mortality in Takotsubo Cardiomyopathy: An Analysis of 28,079 Index Admissions. Cardiovasc Revasc Med. 2019;20(11):973-9. doi:10.1016/j.carrev.2019.08.004.Mitchell A, Marquis F. Can Takotsubo cardiomyopathy be diagnosed by autopsy? Report of a presumed case presenting as cardiac rupture. BMC Clin Pathol. 2017;17:4. doi:10.1186/s12907-017-0045-0.Mitchell A, Marquis F. Can Takotsubo cardiomyopathy be diagnosed by autopsy? Report of a presumed case presenting as cardiac rupture. BMC Clin Pathol. 2017;17:4. doi:10.1186/s12907-017-0045-0.Aoki Y, Kodera S, Watanabe T, et al. Autopsy findings in takotsubo cardiomyopathy with special reference to the autonomic nervous system. Int J Cardiol. 2016;203:236-7. doi:10.1016/j.ijcard.2015.10.121.Aoki Y, Kodera S, Watanabe T, et al. Autopsy findings in takotsubo cardiomyopathy with special reference to the autonomic nervous system. Int J Cardiol. 2016;203:236-7. doi:10.1016/j.ijcard.2015.10.121.Konishi T, Funayama N, Yamamoto T, et al. Acute anterior myocardial infarction complicated by takotsubo syndrome: the value of multimodality imaging. Kardiol Pol. 2020;78(10):1055-6. doi:10.33963/KP.15492.Konishi T, Funayama N, Yamamoto T, et al. Acute anterior myocardial infarction complicated by takotsubo syndrome: the value of multimodality imaging. Kardiol Pol. 2020;78(10):1055-6. doi:10.33963/KP.15492.

The authors declare that there are no conflicts of interest present.